What question did this study set out to answer?

To examine why early kidney transplantation is rarely used as the primary therapy for end-stage renal disease and identify strategies to overcome barriers to its adoption.

February 6, 2008Clinical Journal of the American Society of Nephrology

Kidney Transplantation as Primary Therapy for End-Stage Renal Disease

View Full Paper

Ask AI

Bookmark

Authors

MAMichaël Abécassis SBStephen T. Bartlett ACAllan J. Collins

Discussion

Member takes

Overview

Consensus conference report reveals systemic barriers limiting preemptive kidney transplantation in end-stage renal disease, highlighting the need for earlier education and timely donor evaluation.

Key Points

To examine why early kidney transplantation is rarely used as the primary therapy for end-stage renal disease and identify strategies to overcome barriers to its adoption.
Convened the National Kidney Foundation Kidney Disease Outcomes Quality Initiative (KDOQI) conference in Washington, DC, on March 19–20, 2007.
Engaged 52 expert participants representing transplant centers, dialysis providers, and payers across three work groups focusing on clinical paradigms, education, and health care financing.
Observed that only 2.5% of incident patients with end-stage renal disease receive a kidney transplant as their initial modality of renal replacement therapy, remaining static for over a decade.
Identified critical systemic barriers across educational, clinical, and financial domains, recommending simultaneous transplant evaluation during vascular access referral to expand access to early living donor transplantation.

Cite This Study

Abécassis et al. (2008) studied this question.

synapsesocial.com/papers/6a8ec69bc2a8a91e7c3be7ec https://doi.org/10.2215/cjn.05021107

View Full Paper

Ask AI

Bookmark

February 6, 2008Clinical Journal of the American Society of Nephrology

Kidney Transplantation as Primary Therapy for End-Stage Renal Disease

View Full Paper

Ask AI

Bookmark

Authors

MAMichaël Abécassis SBStephen T. Bartlett ACAllan J. Collins

Discussion

Member takes

Overview

Consensus conference report reveals systemic barriers limiting preemptive kidney transplantation in end-stage renal disease, highlighting the need for earlier education and timely donor evaluation.

Key Points

To examine why early kidney transplantation is rarely used as the primary therapy for end-stage renal disease and identify strategies to overcome barriers to its adoption.
Convened the National Kidney Foundation Kidney Disease Outcomes Quality Initiative (KDOQI) conference in Washington, DC, on March 19–20, 2007.
Engaged 52 expert participants representing transplant centers, dialysis providers, and payers across three work groups focusing on clinical paradigms, education, and health care financing.
Observed that only 2.5% of incident patients with end-stage renal disease receive a kidney transplant as their initial modality of renal replacement therapy, remaining static for over a decade.
Identified critical systemic barriers across educational, clinical, and financial domains, recommending simultaneous transplant evaluation during vascular access referral to expand access to early living donor transplantation.

Cite This Study

Abécassis et al. (2008) studied this question.

synapsesocial.com/papers/6a8ec69bc2a8a91e7c3be7ec https://doi.org/10.2215/cjn.05021107

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark